Macquarie Asset Management on the sale of Macquarie European Infrastructure Fund 4's 40 per cent stake in Hydro Dolomiti Energia (HDE) to a consortium comprised of Equitix Euro Funds, Tages Capital SGR S.p.A., and La Finanziaria Trentina S.p.A. together with local industrial co-investors and institutions. The terms of the transaction imply a valuation of approximately €1 billion for the business.
Eurazeo on its £355 million investment in BMS Group (BMS), a global insurance broker headquartered in the UK, equating to 34 percent of the share capital of BMS.
Oaktree Capital Management on the carve-out and acquisition of the UK private wealth management and investment businesses from Sanlam (renamed atomos), the South African financial services and insurance group.
ADVANZ PHARMA, the global specialty pharmaceuticals company, on its sale by way of scheme of arrangement to Nordic Capital.
Nordic Capital and its portfolio company European Dental Group on the separation and sale of its laboratory activities, including Excent, Flemming Dental and Artinorway Group to Oakley Capital.
The Carlyle Group and its portfolio companies:
- LiveU on the acquisitions of EasyLive and Pacific Live Media; and
- 1E on the acquisition of Exoprise.
